Literature DB >> 18611717

Stability of beta-lactamase inhibitors and beta-lactam antibiotics in parenteral dosage forms and in body fluids and tissue homogenates: a comparative study of sulbactam, clavulanic acid, ampicillin and amoxycillin.

A Wildfeuer1, K Räder.   

Abstract

The beta-lactamase inhibitors and the beta-lactam antibiotics differ appreciably in chemical stability. A comparative study of four different infusion solutions at 4, 25 and 37 degrees C yielded the following descending sequence of stability: sulbactam (CAS 68373-14-8), ampicillin (CAS 69-53-4), amoxycillin (CAS 61336-70-7) and clavulanic acid (CAS 58001-44-8). Especially noteworthy was that the two beta-lactamase inhibitors, sulbactam and clavulanic acid, behaved very differently. Moreover, sulbactam is markedly more stable than clavilanic acid even when incubated at 37 degrees C in body fluids or tissue homogenates. The differences in the chemical stability of these pharmacological agents should be taken into consideration in the therapeutic use of combination preparations such as sulbactam/ampicillin (Unacid(R)) and clavulanic acid/amoxycillin.

Entities:  

Year:  1996        PMID: 18611717

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  4 in total

1.  Pharmacodynamics of ClpP-Activating Antibiotic Combinations against Gram-Positive Pathogens.

Authors:  Nader Mroue; Anu Arya; Autumn Brown Gandt; Cameron Russell; Angel Han; Ekaterina Gavrish; Michael LaFleur
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

2.  Pharmacodynamics modeling to optimize dosage regimens of sulbactam.

Authors:  Sutep Jaruratanasirikul; Wibul Wongpoowarak; Nanchanit Aeinlang; Monchana Jullangkoon
Journal:  Antimicrob Agents Chemother       Date:  2013-05-06       Impact factor: 5.191

3.  In vitro and in vivo properties of BAL30376, a β-lactam and dual beta-lactamase inhibitor combination with enhanced activity against Gram-negative Bacilli that express multiple β-lactamases.

Authors:  Malcolm G P Page; Clothilde Dantier; Eric Desarbre; Bérangère Gaucher; Klaus Gebhardt; Anne Schmitt-Hoffmann
Journal:  Antimicrob Agents Chemother       Date:  2011-01-18       Impact factor: 5.191

4.  Population Pharmacokinetics and Pharmacodynamics Modeling To Optimize Dosage Regimens of Sulbactam in Critically Ill Patients with Severe Sepsis Caused by Acinetobacter baumannii.

Authors:  Sutep Jaruratanasirikul; Wibul Wongpoowarak; Thitima Wattanavijitkul; Waroonrat Sukarnjanaset; Maseetoh Samaeng; Monchana Nawakitrangsan; Natnicha Ingviya
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.